Early Strategies for Migraine Prevention

Developments in migraine treatment indicate the adoption of recent American guidelines that recommend initiating preventive therapy earlier for patients experiencing frequent attacks, especially if these attacks impact their ability to work and carry out daily activities. The new guidelines advise offering preventive treatment to adults who have four or more migraine days per month, focusing on evaluating patients’ responses and adjusting treatment as necessary. A clinical study comparing the drug Atogepant with Topiramate showed that Atogepant is more effective and better tolerated, supporting the use of modern options for migraine prevention. These advances reflect a shift from treating migraines after they occur to early prevention aimed at reducing attack frequency and improving patients’ quality of life.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل